Free Trial
NASDAQ:CINC

CinCor Pharma (CINC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$29.02
$29.35
50-Day Range
$28.73
$29.56
52-Week Range
$10.53
$43.15
Volume
6.35 million shs
Average Volume
818,447 shs
Market Capitalization
$1.27 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CINC stock logo

About CinCor Pharma Stock (NASDAQ:CINC)

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts.

CINC Stock News Headlines

CinCor Pharma Inc.
Impel Pharmaceuticals hit by another C-suite departure
Small Pharma Inc. (DMT.V)
Diabetic Kidney Disease Global Market Report 2023
8-K: IMPEL PHARMACEUTICALS INC
Financial Results for the Year Ended 31 December -3-
NASDAQ Biotechnology Index
ADRs End Higher; AstraZeneca, Barclays Trade Actively
See More Headlines
Receive CINC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CinCor Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CINC
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

Net Income
$-50,370,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($1.74) per share

Miscellaneous

Free Float
36,937,000
Market Cap
$1.27 billion
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Marc M. P. de Garidel (Age 64)
    CEO & Director
    Comp: $776.86k
  • Dr. Mason W. Freeman M.D. (Age 71)
    Chief Medical Officer
    Comp: $285.56k
  • Ms. Catherine Pearce DHSc (Age 46)
    M.B.A., MBA, Co-Founder & COO
  • Mr. Michael W. Kalb CPA (Age 51)
    Exec. VP, CFO & Principal Accounting Officer
  • Ms. Ida Hatoum
    Sr. VP and Head of People, Talent & Culture
  • Hema Keshava
    Corp. Controller

CINC Stock Analysis - Frequently Asked Questions

When did CinCor Pharma IPO?

CinCor Pharma (CINC) raised $176 million in an initial public offering on the week of November 7th 2022. The company issued 11,000,000 shares at a price of $15.00-$17.00 per share.

This page (NASDAQ:CINC) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners